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PP37 
GENECALLING® EXPRESSION ANALYSIS IN ARTICULAR 
CARTILAGE 
GL Pahel, EP Dixon, AA Cole, G Cs-Szabo, KE Quinn 
DepL of Molecular Phannacology, GlaxoSmithKline, RTP, NC; 
Dept of Biochemistry, Rush Medical College, Rush-Presbyterian- 
St. Lukes Medical Center, Chicago,/L; CuraGen Corp., New 
Haven, CN, USA 
Aim: The aim of this study was to use the open ended CuraGen 
expression analysis system to identify those genes whose 
expression most differed between cartilage graded as non-dis- 
eased and osteoarthritic cartilage. 
Methods: Non-diseased (Collins grade 0) knee cartilage came 
from the tibial plateau of donor's identified through the Regional 
Organ Bank of Illinois. Osteoarthritic cartilage came from 
• osteoarthritic patients undergoing total knee replacement. RNA 
was isolated using modifications of published methods. The 
expression analysis was carried out at CuraGen Corporation 
using their proprietary differential display GeneCalling technolo- 
gy. Selected observations were verified by quantitative real time 
PCR (SyberGreen) and extended by in situ analysis. 
Results: We have identified over 50 transcripts exhibiting a 
greater than four-fold ifference between normal and OA carti- 
lage. The direction, although not necessarily the magnitude, of 
many of these changes has been verified by PCR. Among those 
transcripts up regulated in OA were collagen types ], II, III, V, and 
XIV, cartilage glycoprotein-39 (YKL-40), osteopontin, throm- 
bospondin-like, several novel secreted proteins, and novel tyro- 
sine and serine/threonine receptor signalling kinases, Expected 
genes found to be up regulated, but less than four-fold included 
biglycan, aggrecan, tenascin, and osteonectin. Five transcription 
factors and an orphan G-protem coupled receptor were found to 
be down regulated. Expression of pro- and antiapoptosis genes 
was also regulated confirming a role for apoptosis in OA. 
Conclusion: GeneCalling® expression analysis is a robust 
method to identify gene expression changes in cartilage. It has 
been useful in confirming expected changes and in the identifi- 
cation of potential novel targets for therapeutic intervention and 
markers of disease. 
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ASSOCIATION OF HETEROZYGOUS HEMOCHROMATOSIS 
C282Y GENE MUTATION WITH HAND OSTEOARTHRITIS 
J. M. Ross R. Kowlchuck, R Phatatk 
Pennsylvania State Medical School, Hershey, PA, USA 
Aim: Since hereditary hemochromatosis (homozygous tate) usu- 
ally causes a severe form of osteoarthdtis, the aim of the study 
was to determine if radiographic osteoarthritis of the hand is 
associated with an increased prevalence of heterozygous C282Y 
and/or H63D hemochromatosis (HFE) gene mutation. 
Methods: 176 subjects from an academic rheumatology practice 
with hand osteoarthritis (OA) entered a cross-sectional study 
assessing transferrin saturation, ferritin levels, and prevalence of 
HFE genotypes. The diagnosis of radiographic hand QA was 
based on one PA radiograph of both hands with a Kellgren- 
Lawrence grade of =2 in at least one joint in either hand. 
Prevalence of HFE mutations in the local general population 
including subjects with and without OA was determined and 
compared with OA subjects. 
Results: There was a significant increased prevalence of 
C282Y/wild type (wt) HFE mutation in 12.5 % of the OA popula- 
tion compared with a general population prevalence of 7.8% with 
a p-value of 0.029. The significance of increased prevalence of 
OA and heterozygous C282Y mutation was greater in subjects 
360 years of age with p-value of 0.008. There were 23 men with 
OA enrolled with 5 having the C282Y allele. The mean transferrin 
saturation for the wild type OA population was 25.93 and the het- 
erozygous C282Y/wt OA population had a mean of 35.75 with a 
p-value of <0.0001. 
Conclusion: Our data suggests that one subset of OA may be 
related to heterozygous C282Y LIFE mutation and could account 
for up to 12.5% of cases of hand OA in the general population. If 
substantiated the significance of HFE mutations could be much 
greater than that of any other currently known genetic OA asso- 
ciations since HFE testing might be directly tied to simple pre- 
ventative measures with phlebotomy. 
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JAK/STAT BUT NOT ERKI/ERK2 PATHWAY MEDIATES IL- 
6/slL- 6-R DOWN-REGULATION OF COLLAGEN TYPE !1 AND 
AGGRECAN EXPRESSION IN ARTICULAR CHONDROCYTES 
F Richard-Legendre, J-P Pujol, P Bogdanowicz 
Laboratory of Connective Tissue Biochemistry, Faculty of 
Medicine, 14032 CAEN Cedex, France 
Aim: The aim of this study was to analyze the signaling pathways 
of IL-6/slL-6R in articular chondrocytes and their involvement i  
the control of matrix gene expression. 
Methods: Bovine articular chondrocytes, seeded at 5.5x105 
cells/cm 2, were treated by IL-6 (100 to 500 ng/ml) with or without 
IL-6sR (200 to 500 ng/ml) for increasing periods (0 to 30 min) in 
the case of signaling analysis and 24 h for gene expression stud- 
ies. Western-blotting and gel r tardation assays were performed 
with or without MAP kinase inhibitor (PD 98059, 25 ~.M) and STAT 
inhibitor (parthenolide, 25 ~.M). Collagen type 11 and aggrecan 
mRNA levels were determined by Northern blots. 
Results: In the absence of slL-6R, 11_-6 (500 ~g/ml) had a slight 
effect on JAK-1 and JAK-2 phosphorylation. Addition of slL-6R at 
500 ng/ml dramatically increased these effects, with a peak at 15 
min. STATs 1 and 3 were also found to be phosphorylated and 
translocated to the nucleus. Increased binding of protein factors 
to specific STAT responsive elements was observed. ERK 1 and 
ERK 2 were activated by IL-6/slL-6R treatment, with a maximum 
at 30 min. Exposure of cells to IL-6/slL-6R induced an inhibition 
of collagen type II and aggrecan expression. This down-regula- 
tion was abolished in the presence of STAT- but not of MAPK- 
inhibitor, indicating that STAT signaling pathway is implicated in 
the control of these two cartilage specific matrix genes. 
Conclusions: To exert significant effect on chondrocytes, IL-6 
requires the presence of its soluble receptor. The cytokine plays 
a role in the cartilage breakdown through a STAT-induced inhibi- 
tion of collagen type 11 and aggrecan expression. 
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ANALYSIS OF THE ANK GENE REVEALS A HETEROZYGOUS 
MISSENSE MUTATION IN A FRENCH FAMILY WITH CALCI- 
UM PYROPHOSPHATE DEPOSITION DISEASE (CPPDD) 
M Johnson 1 , A Ho 1, R McGrath 2, P Netter 3, D Loeuille 3, P 
Gillet 3, P Jonveaux 3, A Gaucher 3, 
A Reg nato 4, K Gur ey,' D Kings ey', C J W ams 2- 
WHMI and Stanford University, CA, USA; 2Thomas Jefferson 
University, PA, USA, 3UMR 7561, CNRS-UHP, Nancy, France, 
4Robert Wood Johnson Medical School, Camden, NJ, USA 
Aim : To characterize the ANK gene in a large CPPDD kindred 
from the Alsace region of France. 
Methods and Results: ANK codes for an integral membrane pro- 
tein that apparently functions in the transport of inorganic 
